Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include: Cutaneous melanoma, Atypical nevi in non-sun exposed areas, Atypical nevus, and Numerous nevi.
Biomarker and diagnostic research for melanoma, cutaneous malignant, susceptibility to, 3 has been reported in the published literature.
No clinical trials have been registered for melanoma, cutaneous malignant, susceptibility to, 3.
133 publications have been identified in PubMed for melanoma, cutaneous malignant, susceptibility to, 3. Research spans Review / Meta-Analysis (27%), Epidemiology / Natural History (27%), and Diagnostic / Biomarker (16%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 36 | 27% |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 5:31 PM UTC
Online Mendelian Inheritance in Man
Disease patterns and progression |
36 |
27% |
Testing and diagnosis research | 21 | 16% |
Laboratory research | 16 | 12% |
Clinical study results | 13 | 10% |
Patient case studies | 7 | 5% |
New treatment approaches | 4 | 3% |
Landi MT (2026). [PMID: 42183343](https://pubmed.ncbi.nlm.nih.gov/42183343/). *Res Sq*. [Epidemiology / Natural History]
Ma W (2026). [PMID: 42013053](https://pubmed.ncbi.nlm.nih.gov/42013053/). *Melanoma Res*. [Diagnostic / Biomarker]
Puckett Y (2026). [PMID: 29494087](https://pubmed.ncbi.nlm.nih.gov/29494087/). *Unknown Journal*. [Case Report / Case Series]
Wohlfeil SA (2026). [PMID: 42232604](https://pubmed.ncbi.nlm.nih.gov/42232604/). *Oncol Res*. [Review / Meta-Analysis]
Wollina U (2026). [PMID: 41956405](https://pubmed.ncbi.nlm.nih.gov/41956405/). *Clin Dermatol*. [Review / Meta-Analysis]
Dummer R (2026). [PMID: 41698381](https://pubmed.ncbi.nlm.nih.gov/41698381/). *Lancet Oncol*. [Clinical Trial Publication]
Leachman SA (2026). [PMID: 41701495](https://pubmed.ncbi.nlm.nih.gov/41701495/). *JAMA Netw Open*. [Clinical Trial Publication]
Pantić N (2026). [PMID: 41712199](https://pubmed.ncbi.nlm.nih.gov/41712199/). *Acta Dermatovenerol Alp Pannonica Adriat*. [Clinical Trial Publication]
Amrane K (2026). [PMID: 41699280](https://pubmed.ncbi.nlm.nih.gov/41699280/). *Eur J Nucl Med Mol Imaging*. [Diagnostic / Biomarker]
Johansson PA (2026). [PMID: 41673532](https://pubmed.ncbi.nlm.nih.gov/41673532/). *Pigment Cell Melanoma Res*. [Epidemiology / Natural History]